Jose Arrieta, Department of Health and Human Services (HHS) chief information officer (CIO), has resigned from his position with the agency, after spearheading the launch White House COVID-19 decisions system, FedScoop on reported Monday. Arrieta was appointed to the role in May 2019. In the role, Arrieta provided leadership and oversight of the De...
The departments of Health and Human Services and Defense have signed a potential $1.5B agreement with Moderna to produce 100M doses of its COVID-19 vaccine candidate as part of the U.S. government’s Operation Warp Speed....
The Department of Health and Human Services has awarded professional services company DMI a potential five-year, $112M blanket purchase agreement to update the department’s electronic handbook for healthcare business procedures including COVID-19 financial assistance....
Axle Informatics and a Dovel Technologies company have won contracts worth potentially $110M combined to provide program support for the National Institutes of Health’s intramural biomedical and clinical research initiative....
The Department of Health and Human Services’ bioresearch arm and the Department of Defense have earmarked $1.95B to procure 100M doses of an investigational COVID-19 vaccine Pfizer developed with German pharmaceutical company BioNTech....
The departments of Defense and Health and Human Services awarded contracts worth $2.05B combined to biopharmaceutical companies Novavax and Regeneron to accelerate the manufacture of their respective COVID-19 vaccine and treatment candidates....
Bridget Gauer, former director of the National Institutes of Health’s Information Technology Acquisition and Assessment Center, has joined IT consulting firm Cognosante as senior vice president of strategy....
The Department of Health and Human Services has awarded Gaithersburg, Md.-based biopharmaceutical company Emergent BioSolutions a $628M task order to support the production of potential vaccines for the novel coronavirus through 2021....
AstraZeneca and the Department of Health and Human Services have signed a potential $1.2B public-private partnership agreement to further develop a recombinant adenovirus vaccine as potential treatment for the novel coronavirus....
Richmond, Va.-based pharmaceutical manufacturing company Phlow will lead a team comprised of Civica Rx, Ampac Fine Chemicals and the Virginia Commonwealth University’s Medicines for All Institute to produce critical medicines for COVID-19 response through a potential 10-year, $812M contract from the Biomedical Advanced Research and Developme...
